Information collected about functional outcome was based on goals established before pump implant. Goals were determined by a collaboration of patient, caregivers, family and friends, therapists ...

Twenty-one patients received their first pump during the first 5 years (1993-1997) and 29 had their original implant during the second 5 years (1998-2002) of the 10-year experience. Thirteen ...

Some of the key market players operating in the implantable infusion pump market include Medtronic, Flowonix Medical, Intera Oncology, Tandem Diabetes Care, United Therapeutics, ICU Medical, Johnson & ...